Status:
COMPLETED
Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions:
Stable COPD Patients
Eligibility:
MALE
40-70 years
Phase:
PHASE1
Brief Summary
Background: Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality throughout the world which is a preventable as well as treatable disease. It has some important ext...
Detailed Description
1. Introduction: Chronic Obstructive Pulmonary Disease (COPD) is one of the major causes of chronic morbidity and mortality throughout the world . Many people suffer from the disease for years and...
Eligibility Criteria
Inclusion
- Socioeconomic status: Middle class
- Smoker
- Stable patients of COPD with \>1year duration
- Vitamin D3 deficient :
- Serum 25-hydroxycholecalciferol, \[25(OH)D\] level \<30ng/ml (Vitamin D Council 2017)
Exclusion
- With acute exacerbation of any pulmonary diseases, as,
- with acute exacerbation of any cardiac disease, like -
- Uncontrolled systemic hypertension
- Chronic liver disease
- Malignancy
- Use of drugs known to affect vitamin D metabolism within 1 month prior to With biochemical evidence of -
- uncontrolled diabetes mellitus and
- renal insufficiency
- All the criteria mentioned above were scrutinized by taking history and clinical examination, except vitamin D3 deficiency, uncontrolled diabetes mellitus and renal insufficiency, which were diagnosed biochemically.
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2018
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03781895
Start Date
March 1 2017
End Date
February 1 2018
Last Update
January 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samia Hassan
Dhaka, Bangladesh, 1213